← All candidates
One insider buy in the last year — $245.3K in all.
14 filings on record.
LUCDLucid Diagnostics Inc.
NasdaqCM · Healthcare · $206.03M
$0.8970
+5.29% · Sep 16
One insider buy in the last year — $245.3K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 1 buy◆ 6 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$206.03M
Float
140.6M
74% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Matheis Dennis
Bought $245.3K on May 20 — 245,000 sh @ $1.00, held direct, 24% of their stake.
1 of 1 position beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
8 more transactions on Pro →Context
Wall St
$4.00 avg target
+345.9% vs today · 5 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
0 of 4 quarters beat
Q2 '26−$0.06 act−$0.00
Q1 '26−$0.07 act−$0.01
Q4 '25−$0.10 act−$0.01
Q3 '25−$0.10 act−$0.01
Coverage
Lucid Diagnostics (LUCD) Q2 2026 Earnings Call TranscriptMotley Fool · 3w agoLucid Diagnostics Eyes Medicare Catalyst for EsoGuard GrowthMarketBeat · 08-15Lucid Diagnostics Inc. Q2 2026 Earnings Call SummaryMoby · 08-14Lucid Diagnostics Inc (LUCD) (Q2 2026) Earnings Call Highlights: Strategic Pivot to High-Value ...
The file stays open
14 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice